Kabadi U M
Veterans Affairs Medical Center, Des Moines, Iowa, USA.
J Endocrinol Invest. 2001 Mar;24(3):178-82. doi: 10.1007/BF03343839.
Both the basal TSH concentration and the TSH response to iv TRH administration are noted to be decreased at the peak of an acute critical illness. Moreover, an impaired release from hypothalamus has been documented in rats with uncontrolled diabetes, suggesting hypothalamic dysfunction in a non-thyroidal illness. However, the exact inference and mechanism of this impaired TSH secretary pattern is not well defined in humans during a non-thyroidal illness. Therefore, this study assessed hypothalamic pituitary thyroid axis by determination by T4, T3, and T3 resin uptake prior to and TSH concentrations, prior to, as well as following, iv TRH administration at an interval of 30 min up to 2 hours on three successive mornings during a severe, critical, fatal illness in five previously known euthyroid subjects. TSH response to iv TRH administration was expressed as a maximal absolute change (delta TSH) and a cumulative response (CR TSH), calculated as the sum of changes from the basal level at each specific time period for up to 120 min. Serum T4, T3 and TSH concentrations on day 1 of the TRH administration were significantly lower than normal values as well as the values documented previously in the same individuals prior to hospitalization. T3 resin uptake was increased simultaneously. Moreover, serum T4, T3, and T3 resin uptake remained significantly unaltered on three successive days of iv TRH administration. However, basal serum TSH rose significantly with a parallel TSH response to iv TRH administration, as reflected by a progressive rise in delta TSH as well as CR TSH over this three-day period, with normalization of the TSH responses by the third day. Therefore, impaired TSH secretary pattern and altered thyroid hormone concentrations noted in subjects with acute critical illness may be attributed to the presence of a transient hypothalamic hypothyroidism.
在急性危重病的高峰期,基础促甲状腺激素(TSH)浓度以及静脉注射促甲状腺激素释放激素(TRH)后的TSH反应均会降低。此外,在患有未控制糖尿病的大鼠中已证实存在下丘脑释放功能受损,这表明在非甲状腺疾病中存在下丘脑功能障碍。然而,在非甲状腺疾病患者中,这种TSH分泌模式受损的确切推断和机制尚不清楚。因此,本研究在五名先前已知甲状腺功能正常的受试者处于严重、危急、致命疾病期间,连续三个早晨,在静脉注射TRH之前、注射后以及以30分钟的间隔直至2小时,通过测定T4、T3和T3树脂摄取以及TSH浓度来评估下丘脑 - 垂体 - 甲状腺轴。静脉注射TRH后的TSH反应以最大绝对变化量(ΔTSH)和累积反应(CR TSH)表示,计算方法是在长达120分钟的每个特定时间段内从基础水平的变化总和。在给予TRH的第1天,血清T4、T3和TSH浓度显著低于正常值以及这些个体先前住院前记录的值。同时,T3树脂摄取增加。此外,在静脉注射TRH的连续三天中,血清T4、T3和T3树脂摄取保持显著不变。然而,基础血清TSH显著升高,同时对静脉注射TRH的TSH反应也升高,这表现为在这三天期间ΔTSH以及CR TSH逐渐升高,到第三天TSH反应恢复正常。因此,急性危重病患者中TSH分泌模式受损和甲状腺激素浓度改变可能归因于短暂性下丘脑甲状腺功能减退的存在。